Environmental Enteric Dysfunction
18
2
2
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.6%
1 terminated out of 18 trials
90.0%
+3.5% vs benchmark
0%
0 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED)
Capsule Endomicroscopy for Visualization of the Small Intestine in EED Population in Pakistan
SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
Maternal Probiotic Intervention to Improve Gut Health - Trial II - Bangladesh
Indispensable Amino Acids Bioavailability in Children With Environmental Enteropathy Dysfunction (IAA-EED)
OCT Guided Trans Nasal Imaging of the Small Intestine in Adults
Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories
Maternal Probiotic Intervention to Improve Gut Health
Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal
Eggs for Gut Health
Maternal Probiotic Intervention to Improve Gut Health
Acceptability and Efficacy of Enterade (VS001) in Children at Risk for Environmental Enteric Dysfunction in Bangladesh
Safety, Acceptability, and Feasibility of Enterade®
The Effect of Bovine Colostrum/ Egg Supplementation in Young Malawian Children
Effects of EED on Zn Absorption and Retention in Children From a MNP
Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
PTM202 for the Treatment of Environmental Enteric Dysfunction (EED)
Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction